PT2017265E - Compostos condensados que inibem o receptor vanilóide de subtipo 1 (vr1) - Google Patents

Compostos condensados que inibem o receptor vanilóide de subtipo 1 (vr1) Download PDF

Info

Publication number: PT2017265E
Authority: PT; Portugal
Prior art keywords: receptor; compounds; fused compounds; subtype; inhibit vanilloid
Prior art date: 2003-06-12

Application number

PT08166079T

Other languages

English (en)

Inventor

Chih-Hung Lee

Erol K Bayburt

Arthur Gomtsyan

John R Koenig

Robert Schmidt

Kirill Lukin

Gilles Chambournier

Russel D Cink

Margaret Hsu

Robert M Leanna

Original Assignee

Abbott Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-06-12

Filing date

2004-06-10

Publication date

2011-07-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33555102&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT2017265(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-06-12 Priority claimed from US10/459,925 external-priority patent/US7015233B2/en

2004-06-09 Priority claimed from US10/864,068 external-priority patent/US7375126B2/en

2004-06-10 Application filed by Abbott Lab filed Critical Abbott Lab

2011-07-29 Publication of PT2017265E publication Critical patent/PT2017265E/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/06—Anti-spasmodics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Urology & Nephrology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Other In-Based Heterocyclic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Materials For Photolithography (AREA)

PT08166079T 2003-06-12 2004-06-10 Compostos condensados que inibem o receptor vanilóide de subtipo 1 (vr1) PT2017265E (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US10/459,925 US7015233B2 (en)	2003-06-12	2003-06-12	Fused compounds that inhibit vanilloid subtype 1 (VR1) receptor
US10/864,068 US7375126B2 (en)	2003-06-12	2004-06-09	Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor

Publications (1)

Publication Number	Publication Date
PT2017265E true PT2017265E (pt)	2011-07-29

Family

ID=33555102

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PT08166079T PT2017265E (pt)	2003-06-12	2004-06-10	Compostos condensados que inibem o receptor vanilóide de subtipo 1 (vr1)
PT04754996T PT1658269E (pt)	2003-06-12	2004-06-10	Compostos condensados que inibem o receptor vanilóide de subtipo 1 (vr1)

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
PT04754996T PT1658269E (pt)	2003-06-12	2004-06-10	Compostos condensados que inibem o receptor vanilóide de subtipo 1 (vr1)

Country Status (20)

Country	Link
EP (2)	EP1658269B1 (pt)
JP (2)	JP4857113B2 (pt)
KR (2)	KR101150324B1 (pt)
CN (1)	CN102617464A (pt)
AT (2)	ATE510824T1 (pt)
AU (2)	AU2004247721C1 (pt)
BR (1)	BRPI0411116A (pt)
CA (2)	CA2756058A1 (pt)
CY (2)	CY1108713T1 (pt)
DE (1)	DE602004017329D1 (pt)
DK (2)	DK1658269T3 (pt)
ES (1)	ES2318308T3 (pt)
IL (4)	IL172457A (pt)
MX (1)	MXPA05013550A (pt)
NZ (3)	NZ590234A (pt)
PL (2)	PL2017265T3 (pt)
PT (2)	PT2017265E (pt)
SI (2)	SI2017265T1 (pt)
TW (3)	TW201300361A (pt)
WO (1)	WO2004111009A1 (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1608319A4 (en)	2003-04-03	2007-02-28	Univ California	IMPROVED HEMMER FOR SOLUBLE EPOXY HYDROLASE
CA2559665A1 (en)	2004-03-16	2005-09-29	The Regents Of The University Of California	Reducing nephropathy with inhibitors of soluble epoxide hydrolase and epoxyeicosanoids
ZA200703613B (en)	2004-10-20	2009-05-27	Univ California	Improved inhibitors for the soluble epoxide hydrolase
JP2008523071A (ja)	2004-12-07	2008-07-03	ルーカスファーマシューティカルズ，インコーポレイテッド	Ｍａｐキナーゼの尿素インヒビター
JP2008523072A (ja)	2004-12-07	2008-07-03	ルーカスファーマシューティカルズ，インコーポレイテッド	タンパク質キナーゼの阻害剤
US7842703B2 (en)	2005-10-07	2010-11-30	Glenmark Pharmaceuticals S.A.	Substituted benzofused derivatives and their use as vanilloid receptor ligands
JP2009513642A (ja) *	2005-10-25	2009-04-02	アボット・ラボラトリーズ	低水溶解度の薬剤を含む製剤およびそれの使用方法
CN102516176A (zh) *	2005-10-28	2012-06-27	雅培制药有限公司	抑制trpv1受体的吲唑衍生物
TW200808723A (en) *	2006-03-13	2008-02-16	Univ California	Conformationally restricted urea inhibitors of soluble epoxide hydrolase
BRPI0710507A2 (pt) *	2006-04-18	2011-08-16	Abbott Lab	Antagonistas do receptor vanilóide de subtipo 1 (vr1) e usos destes
WO2009081222A1 (en)	2007-12-21	2009-07-02	Glenmark Pharmaceuticals, S.A.	Substituted tricyclic pyridine or pyrimidine vanilloid receptor ligands
KR101619341B1 (ko)	2008-01-28	2016-05-11	(주)아모레퍼시픽	바닐로이드 수용체 길항체로서의 신규 화합물, 이의 이성질체 또는 약제학적으로 허용가능한 염, 및 이를 함유하는 약학 조성물
US8691855B2 (en)	2008-07-02	2014-04-08	Amorepacific Corporation	Compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist and pharmaceutical compositions containing the same
CA2737768A1 (en) *	2008-10-17	2010-04-22	Abbott Laboratories	Trpv1 antagonists
US9296693B2 (en)	2010-01-29	2016-03-29	The Regents Of The University Of California	Acyl piperidine inhibitors of soluble epoxide hydrolase
SI2712358T1 (sl)	2011-05-13	2017-03-31	Array Biopharma, Inc.	Spojine pirolidinil sečnine, pirolidinil tiosečnine in pirolidinil gvanidina kot inhibitorji kinaze trka
US9375005B2 (en) *	2012-05-09	2016-06-28	Bayer Cropscience Ag	5-halogenopyrazole indanyl carboxamides
WO2014078408A1 (en)	2012-11-13	2014-05-22	Array Biopharma Inc.	Bicyclic heteroaryl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
US9809578B2 (en)	2012-11-13	2017-11-07	Array Biopharma Inc.	Pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trkA kinase inhibitors
WO2014078325A1 (en)	2012-11-13	2014-05-22	Array Biopharma Inc.	N-(monocyclic aryl),n'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
ES2664331T3 (es)	2012-11-13	2018-04-19	Array Biopharma, Inc.	Compuestos de N-pirrolidinilo, N'-pirazolilurea, tiourea, guanidina y cianoguanidina como inhibidores de la cinasa Trka
WO2014078322A1 (en)	2012-11-13	2014-05-22	Array Biopharma Inc.	Thiazolyl and oxazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
RU2664541C2 (ru)	2012-11-13	2018-08-20	Эррэй Биофарма Инк.	Бициклические соединения мочевины, тиомочевины, гуанидина и цианогуанидина, пригодные для лечения боли
WO2014078331A1 (en)	2012-11-13	2014-05-22	Array Biopharma Inc.	N-(arylalkyl)-n'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
WO2014078328A1 (en)	2012-11-13	2014-05-22	Array Biopharma Inc.	N-bicyclic aryl,n'-pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
US9790178B2 (en)	2012-11-13	2017-10-17	Array Biopharma Inc.	Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
US9828360B2 (en)	2012-11-13	2017-11-28	Array Biopharma Inc.	Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
PT3154959T (pt)	2014-05-15	2019-09-24	Array Biopharma Inc	1-((3s,4r)-4-(3-fluorofenil)-1-(2-metoxietil)-pirrolidin-3-il)-3-(4-metil-3-(2-metilpirimidin-5-il)-1-fenil-1h-pirazol-5-il)ureia como inibidor da cinase trka
AU2017257151A1 (en) *	2016-04-29	2018-11-15	Board Of Regents, The University Of Texas System	Sigma receptor binders
DE102022104759A1 (de)	2022-02-28	2023-08-31	SCi Kontor GmbH	Co-Kristall-Screening Verfahren, insbesondere zur Herstellung von Co-Kristallen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW536734B (en) *	2000-07-31	2003-06-11	Clariant Int Ltd	Process for manufacturing a microelectronic device
AU2002325381A1 (en) *	2001-07-31	2003-02-24	Bayer Healthcare Ag	Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists
JP2003192587A (ja) *	2001-12-26	2003-07-09	Bayer Ag	尿素誘導体
CA2476936A1 (en) *	2002-02-20	2003-08-28	Chih-Hung Lee	Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
GB0206876D0 (en) *	2002-03-22	2002-05-01	Merck Sharp & Dohme	Therapeutic agents
ATE533743T1 (de) *	2002-05-17	2011-12-15	Janssen Pharmaceutica Nv	Harnstoffderivate von aminotetralin als modulatoren des vanilloid-rezeptors vr1

2004
- 2004-06-10 PL PL08166079T patent/PL2017265T3/pl unknown
- 2004-06-10 NZ NZ590234A patent/NZ590234A/en not_active IP Right Cessation
- 2004-06-10 CA CA2756058A patent/CA2756058A1/en not_active Abandoned
- 2004-06-10 AT AT08166079T patent/ATE510824T1/de active
- 2004-06-10 KR KR1020117017610A patent/KR101150324B1/ko not_active Expired - Fee Related
- 2004-06-10 PT PT08166079T patent/PT2017265E/pt unknown
- 2004-06-10 DK DK04754996T patent/DK1658269T3/da active
- 2004-06-10 CN CN2012100573625A patent/CN102617464A/zh active Pending
- 2004-06-10 NZ NZ578264A patent/NZ578264A/en not_active IP Right Cessation
- 2004-06-10 MX MXPA05013550A patent/MXPA05013550A/es active IP Right Grant
- 2004-06-10 JP JP2006533722A patent/JP4857113B2/ja not_active Expired - Fee Related
- 2004-06-10 EP EP04754996A patent/EP1658269B1/en not_active Expired - Lifetime
- 2004-06-10 DK DK08166079.7T patent/DK2017265T3/da active
- 2004-06-10 ES ES04754996T patent/ES2318308T3/es not_active Expired - Lifetime
- 2004-06-10 AT AT04754996T patent/ATE411982T1/de active
- 2004-06-10 DE DE602004017329T patent/DE602004017329D1/de not_active Expired - Lifetime
- 2004-06-10 WO PCT/US2004/018590 patent/WO2004111009A1/en not_active Ceased
- 2004-06-10 SI SI200431715T patent/SI2017265T1/sl unknown
- 2004-06-10 CA CA2526872A patent/CA2526872C/en not_active Expired - Fee Related
- 2004-06-10 AU AU2004247721A patent/AU2004247721C1/en not_active Ceased
- 2004-06-10 NZ NZ543713A patent/NZ543713A/en not_active IP Right Cessation
- 2004-06-10 KR KR1020057023829A patent/KR101138216B1/ko not_active Expired - Fee Related
- 2004-06-10 PT PT04754996T patent/PT1658269E/pt unknown
- 2004-06-10 BR BRPI0411116-8A patent/BRPI0411116A/pt not_active IP Right Cessation
- 2004-06-10 PL PL04754996T patent/PL1658269T3/pl unknown
- 2004-06-10 EP EP08166079A patent/EP2017265B1/en not_active Expired - Lifetime
- 2004-06-10 SI SI200430995T patent/SI1658269T1/sl unknown
- 2004-06-14 TW TW101107398A patent/TW201300361A/zh unknown
- 2004-06-14 TW TW093117059A patent/TWI394569B/zh not_active IP Right Cessation
- 2004-06-14 TW TW099119548A patent/TWI366461B/zh not_active IP Right Cessation
2005
- 2005-12-08 IL IL172457A patent/IL172457A/en not_active IP Right Cessation
2009
- 2009-01-14 CY CY20091100044T patent/CY1108713T1/el unknown
2010
- 2010-08-01 IL IL207335A patent/IL207335A/en not_active IP Right Cessation
- 2010-12-17 AU AU2010257277A patent/AU2010257277B2/en not_active Ceased
2011
- 2011-03-07 JP JP2011049274A patent/JP2011153148A/ja active Pending
- 2011-07-28 CY CY20111100738T patent/CY1111945T1/el unknown
- 2011-10-27 IL IL215997A patent/IL215997A0/en unknown
- 2011-10-30 IL IL216046A patent/IL216046A0/en unknown

Also Published As

Publication number	Publication date
AU2010257277A1 (en)	2011-01-13
JP2011153148A (ja)	2011-08-11
WO2004111009A1 (en)	2004-12-23
PL1658269T3 (pl)	2009-08-31
TW201300361A (zh)	2013-01-01
CN102617464A (zh)	2012-08-01
BRPI0411116A (pt)	2006-07-18
CA2526872A1 (en)	2004-12-23
AU2004247721C1 (en)	2011-12-22
IL172457A (en)	2011-12-29
SI2017265T1 (sl)	2011-09-30
EP2017265A1 (en)	2009-01-21
CY1108713T1 (el)	2014-04-09
AU2004247721B2 (en)	2011-01-20
SI1658269T1 (sl)	2009-04-30
AU2010257277B2 (en)	2011-08-18
IL207335A0 (en)	2010-12-30
DE602004017329D1 (de)	2008-12-04
NZ578264A (en)	2011-02-25
CA2526872C (en)	2013-02-05
KR101138216B1 (ko)	2012-09-05
HK1126488A1 (en)	2009-09-04
CY1111945T1 (el)	2015-11-04
EP1658269A1 (en)	2006-05-24
TWI366461B (en)	2012-06-21
AU2004247721A1 (en)	2004-12-23
ES2318308T3 (es)	2009-05-01
KR20110089464A (ko)	2011-08-08
PT1658269E (pt)	2009-01-09
TWI394569B (zh)	2013-05-01
DK1658269T3 (da)	2009-01-12
KR20060058769A (ko)	2006-05-30
EP2017265B1 (en)	2011-05-25
JP2007500753A (ja)	2007-01-18
JP4857113B2 (ja)	2012-01-18
HK1093727A1 (en)	2007-03-09
NZ590234A (en)	2012-07-27
IL216046A0 (en)	2011-12-29
CA2756058A1 (en)	2004-12-23
KR101150324B1 (ko)	2012-06-13
ATE510824T1 (de)	2011-06-15
TW200509926A (en)	2005-03-16
DK2017265T3 (da)	2011-09-19
EP1658269B1 (en)	2008-10-22
TW201038269A (en)	2010-11-01
PL2017265T3 (pl)	2011-11-30
ATE411982T1 (de)	2008-11-15
IL207335A (en)	2012-02-29
IL215997A0 (en)	2011-12-29
IL172457A0 (en)	2006-04-10
NZ543713A (en)	2009-08-28
MXPA05013550A (es)	2006-04-05

Publication	Publication Date	Title
IL207335A0 (en)	2010-12-30	Fused compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
IL173269A0 (en)	2006-06-11	Compounds for inflammation and immune-related uses
AU2003259747A8 (en)	2004-03-11	Substituted hihydroquinolines as glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
TW200621232A (en)	2006-07-01	Compounds for inflammation and immune-related uses
EP1072592A3 (en)	2001-02-07	4-arylpiperidine derivatives for the treatment of pruritus
WO2004020431A3 (en)	2004-05-13	Novel benzoimidazole derivatives useful as antiproliferative agents
MY128063A (en)	2007-01-31	Aromatic heterocyclic compound as antiinflammatory agents
EP1467982B8 (en)	2007-04-11	Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them, and uses thereof
IS6275A (is)	2002-02-18	Heteróhringa efnasambönd og notkun þeirra sem mótlyf efnaskiptaglútamatviðtaka
WO2006062981A3 (en)	2007-02-22	Antagonists to the vanilloid receptor subtype 1 (vr1) and uses thereof
PL1689387T3 (pl)	2012-02-29	Bicykliczne inhibitory MEK i sposoby ich otrzymywania
MXPA04006031A (es)	2004-09-27	Compuestos para el tratamiento de trastornos inflamatorios.
WO2005040121A3 (en)	2005-06-23	Amides that inhibit vanilloid receptor subtype 1 (vr1) receptor
WO2006063178A3 (en)	2006-08-24	Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (vr1) and uses thereof
WO2005056535A8 (en)	2006-06-15	1,2,3-triazole amide derivatives as inhibitors of cytokine production
MX2007007100A (es)	2007-06-22	Benzisotiazol-1,1-dioxido que actua como antagonistas para el subtipo 1 del receptor de vanilloida (vr1) y usos de los mismos.
MXPA04005988A (es)	2004-09-27	3,4-dihidro-1h-isoquinolin-2-il-derivados.
WO2006029210A3 (en)	2006-05-04	Acyclic 1,3-diamines and uses therefor
CA2309485A1 (en)	2000-11-28	New 4-arylpiperidine derivatives for the treatment of pruritus